Tourmaline Bio, Inc.

Q4 2024 13F Holders

Symbol
TRML
CUSIP
89157D105
Type
Equity
Class
COM
Num filings
105
Total reported value, excl. options
$464 M
Manager Report Date Value ($000) Shares Option Type